66Health
Mirabegron Sustained-release Tablets
ImportedChemical Drug

Mirabegron Sustained-release Tablets

Drug Information

Generic name米拉贝隆缓释片
Trade name贝坦利
English nameMirabegron Sustained-release Tablets
Dosage formTablet
Specification50mg
CategoryChemical Drug
Approval no.国药准字J20180019
Drug code86901076000225
OriginImported
Approval date2019-08-23

Source: NMPA (National Medical Products Administration) drug registration data, for reference only. This page does not include dosage or indications; follow your doctor's advice and read the package insert.